Rock Springs Capital Management LP Sells 192,000 Shares of SPDR S&P Biotech ETF $XBI

Rock Springs Capital Management LP trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 30,000 shares of the exchange traded fund’s stock after selling 192,000 shares during the quarter. Rock Springs Capital Management LP’s holdings in SPDR S&P Biotech ETF were worth $3,832,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. AQR Capital Management LLC increased its stake in SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares during the period. Marshall Wace LLP grew its holdings in shares of SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter worth about $260,000. Ameriprise Financial Inc. increased its stake in SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after buying an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC lifted its holdings in SPDR S&P Biotech ETF by 3.7% during the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after buying an additional 193 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $150.59 on Tuesday. The stock has a market cap of $10.14 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The firm has a 50-day moving average of $144.70 and a two-hundred day moving average of $133.73. SPDR S&P Biotech ETF has a 1 year low of $84.39 and a 1 year high of $165.71.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.